ArticleSmall (Weinheim an der Bergstrasse, Germany)2025
Optimized Rear-Interface Passivation of SnS Thin-Film Solar Cells Using a Controlled Germanium Oxide Interlayer for Enhanced Photovoltaic Performance.
Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Optimized Rear-Interface Passivation of SnS Thin-Film Solar Cells Using a Controlled Germanium Oxide Interlayer for Enhanced Photovoltaic Performance.Small (Weinheim an der Bergstrasse, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Tin monosulfide (SnS) holds significant promise as a sustainable, earth-abundant absorber for thin-film solar cells (TFSCs), however, device efficiencies remain hindered by detrimental interfacial quality at the rear contact. Defect states, interfacial reactions, and uncontrolled alkali diffusion at the Mo/SnS interface introduce severe recombination losses, limiting photovoltaic (PV) performance. Here, a tailored back-interface engineering strategy employing a thermally evaporated and controlled oxidized Germanium (germanium oxide GeO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.